Demo Sign up Log In

Heron Therapeutics Inc (HRTX)

R&D Expenses

$2.70M

Quarterly · Period ending: Jun 30, 2026 · USD

HRTX R&D Expenses

Latest reported$2.70Mperiod endingJun 30, 2026

Latest reported$2.70Mperiod endingJun 30, 2026

HRTX Quarterly R&D Expenses ($0.00 → $2.70M)

Quarterly R&D Expenses

High-resolution chart · PNG

HRTX r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	1,544,000
Mar 31, 2001	1,378,000
Dec 31, 2000	1,518,000
Sep 30, 2000	790,295
Jun 30, 2000	850,631
Mar 31, 2000	892,248
Dec 31, 1999	2,200,000
Sep 30, 1999	1,000,000
Jun 30, 1999	1,000,000
Mar 31, 1999	1,100,000
Dec 31, 1998	1,200,000
Sep 30, 1998	1,000,000
Jun 30, 1998	1,200,000
Mar 31, 1998	1,000,000
Dec 31, 1997	1,000,000
Sep 30, 1997	900,000
Jun 30, 1997	900,000
Mar 31, 1997	900,000
Dec 31, 1996	600,000
Sep 30, 1996	1,000,000
Jul 25, 1996	1,000,000
Mar 31, 1996	900,000
Dec 31, 1995	1,200,000
Sep 30, 1995	900,000
Jun 30, 1995	1,000,000
Mar 31, 1995	900,000
Dec 31, 1994	1,500,000
Sep 30, 1994	1,700,000
Jun 30, 1994	1,900,000
Mar 31, 1994	1,300,000
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Dec 31, 1987	0
Sep 30, 1987	0
Jun 30, 1987	0
Mar 31, 1987	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.